Therefore, the lower level of Th17 cells in F1 mice likely contributes to the resistance of F1 mice, rendering them free of disease for a prolonged time period

Therefore, the lower level of Th17 cells in F1 mice likely contributes to the resistance of F1 mice, rendering them free of disease for a prolonged time period. Unlike the potential involvement of CD4+T cells in viral pathogenesis, CD8+T cells are known to play an important role in clearing viruses from infected hosts (5,15,39,43). and induction of protective T cell responses appear to play a crucial role in disease resistance. Although the F1 mice are resistant to disease, the level of viral RNA in the CNS was intermediate between those of SJL/J and C57BL/6 mice, indicating the presence of a threshold of viral expression Alimemazine hemitartrate for pathogenesis. Intracerebral contamination of susceptible mice with Theiler’s murine encephalomyelitis virus (TMEV) induces a chronic, progressive demyelinating disease that is clinically and histopathologically similar to a form of human multiple sclerosis (MS) (25). In addition, the various immunological and genetic factors that affect disease outcome in TMEV-infected mice closely parallel those associated with the development of MS (23). Combined with a suspected viral etiology for MS (1,13,46), these similarities make TMEV-induced demyelinating disease (TMEV-IDD) an attractive and relevant infectious model for investigating this human demyelinating disease. Development Alimemazine hemitartrate of TMEV-IDD in highly susceptible SJL/J (H-2s) mice (SJL mice) is usually associated with chronic viral persistence in the central nervous system (CNS) (7,26,44), whereas resistant C57BL/6 (H-2b) mice (B6 mice) clear the virus within 2 to 4 weeks of contamination (41). Thus, viral persistence appears to be a critical factor in Alimemazine hemitartrate the disease development. Interestingly, F1 mice crossed between resistant B6 and susceptible SJL mice [(C57BL/6 SJL/J)F1 mice; herein referred to as F1 mice] are able to clear the virus and are relatively resistant to TMEV-IDD, indicating that genes involved in the resistance Alimemazine hemitartrate are dominant genetic traits (8,9,27). Resistance to TMEV-IDD has been closely associated with the major histocompatibility Alimemazine hemitartrate complex (MHC) class I locus (27,42), which suggests that class I-restricted CD8+T cells are an important mediator of the protection and/or pathogenesis. It has been of great interest to define and characterize the class I-restricted CD8+T cell responses in both resistant and susceptible mice. Resistant H-2bmice mount CD8+T cell responses to one highly dominant (VP2121-130) (6,12,19) and two minor (VP2165-173and VP3110-120) viral epitopes of TMEV (29). Similarly, CNS-infiltrating CD8+T cells in susceptible SJL mice recognize a dominant (VP3159-166) Rabbit Polyclonal to iNOS (phospho-Tyr151) and two subdominant (VP3173-181and VP111-20) epitopes (20). Interestingly, all of the epitopes for CD8+T cells from resistant B6 mice are restricted by H-2Db, whereas CD8+T cells from susceptible SJL mice recognize the epitopes in conjunction with H-2Ks. Despite the comparable proportions of CNS-infiltrating CD8+T cells that recognize TMEV epitopes in both resistant B6 and susceptible SJL mice, the overall number of CD8+T cells in the CNS is usually significantly lower in virus-infected SJL mice than in resistant B6 mice (30). Therefore, the inefficient viral clearance in mice that are susceptible to TMEV-IDD may reflect an insufficient number of, rather than deficient function of, protective CD8+T cells compared to those in the resistant mice. In contrast to the protective role of virus-specific CD8+T cells, CD4+T cell responses are considered to play a pivotal role in the pathogenesis of demyelinating disease (22,38,48). Our recent studies exhibited that Th17 cells in particular play a critical pathogenic role; hence, the treatment of susceptible mice with anti-interleukin 17 (anti-IL-17) antibody renders them resistant to the disease (16). Therefore, it is likely that a balance between the protective virus-specific CD8+T cell responses and pathogenic Th17 cell levels may determine the outcome of disease development. Despite extensive studies on immunological parameters of resistant and susceptible strains, the immune response levels, the CD4+T cell types, and the distribution of MHC haplotype-restricted T cells in resistant F1 mice expressing both MHCs are unknown. For clinical application, it is important to understand how protective and pathogenic immune responses function in an environment where the expression of resistant and susceptible genes are mixed. In this study, we directly compared the TMEV-specific CD4+and CD8+T cell responses among.